Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,514 | -101,594 | -62,845 | -78,729 | -39,876 |
| Depreciation Amortization | -661 | -407 | -118 | -113 | -16 |
| Accounts payable and accrued liabilities | 1,785 | -825 | 406 | 750 | 1,630 |
| Other Working Capital | -9,975 | -67,199 | -69,600 | -15,172 | -10,016 |
| Other Operating Activity | 10,005 | 31,139 | 22,989 | 15,048 | 6,581 |
| Operating Cash Flow | $-44,360 | $-138,886 | $-109,168 | $-78,216 | $-41,697 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2 | -1,048 | -826 | -675 | -51 |
| Purchase Of Investment | -54,412 | -264,457 | -89,437 | -71,100 | -47,164 |
| Sale Of Investment | 64,045 | 224,640 | 185,115 | 119,150 | 77,812 |
| Investing Cash Flow | $9,635 | $-40,865 | $94,852 | $47,375 | $30,597 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,383 | 222,536 | 3,124 | 583 | 2 |
| Other Financing Activity | -537 | -36 | 0 | 0 | 0 |
| Financing Cash Flow | $79,846 | $222,500 | $3,124 | $583 | $2 |
| Beginning Cash Position | 114,846 | 72,097 | 72,097 | 72,097 | 72,097 |
| End Cash Position | 159,967 | 114,846 | 60,905 | 41,839 | 60,999 |
| Net Cash Flow | $45,121 | $42,749 | $-11,192 | $-30,258 | $-11,098 |
| Free Cash Flow | |||||
| Operating Cash Flow | -44,360 | -138,886 | -109,168 | -78,216 | -41,697 |
| Capital Expenditure | 2 | -1,048 | -826 | -675 | -51 |
| Free Cash Flow | -44,358 | -139,934 | -109,994 | -78,891 | -41,748 |